Primary Pulmonary Hypertension: Improved Long-Term Effects and Survival With Continuous Intravenous Epoprostenol Infusion-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Primary Pulmonary Hypertension: Improved Long-Term Effects and Survival With Continuous Intravenous Epoprostenol Infusion

Published:1997-08 Issue:2 Volume:30 Page:343-349
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Shapiro Shelley M,Oudiz Ronald J,Cao Tiesheng,Romano Matthew A,Beckmann X.Joy,Georgiou Demitrios,Mandayam Sarathy,Ginzton Leonard E,Brundage Bruce H

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference12 articles.

1. Primary pulmonary hypertension;Glanville;Chest,1987

2. Survival in patients with primary pulmonary hypertension;D’Alonzo;Ann Intern Med,1991

3. The acute administration of vasodilators in primary pulmonary hypertension;Weir;Am Rev Respir Dis,1980

4. High-dose calcium channel-blocking therapy for primary pulmonary hypertension;Rich;Circulation,1987

5. Treatment of pulmonary hypertension with infusion of prostacyclin (epoprostenol);Rubin;Ann Intern Med,1990

Cited by 262 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Echocardiographic diagnosis and clinical implications of wide-open tricuspid regurgitation for evaluating right ventricular dysfunction in the emergency department;The American Journal of Emergency Medicine;2024-06

2. The Role of Echocardiography in the Diagnosis and Prognosis of Pulmonary Hypertension;Journal of Personalized Medicine;2024-04-29

3. Advances in the discovery of drugs that treat pulmonary arterial hypertension;Expert Opinion on Drug Discovery;2023-04-03

4. New Tricks for an Old Drug: Prostacyclins and Right Ventricular Contractility in Pulmonary Arterial Hypertension;American Journal of Respiratory and Critical Care Medicine;2022-07-01

5. Epoprostenol for the treatment of pulmonary arterial hypertension;Expert Review of Clinical Pharmacology;2021-06-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3